Seroepidemiology of helminths and the association with severe malaria among infants and young children in Tanzania

Jennifer L Kwan, Amy E Seitz, Michal Fried, Kun-Lin Lee, Simon Metenou, Robert Morrison, Edward Kabyemela, Thomas B Nutman, D Rebecca Prevots, Patrick E Duffy, Jennifer L Kwan, Amy E Seitz, Michal Fried, Kun-Lin Lee, Simon Metenou, Robert Morrison, Edward Kabyemela, Thomas B Nutman, D Rebecca Prevots, Patrick E Duffy

Abstract

The disease burden of Wuchereria bancrofti and Plasmodium falciparum malaria is high, particularly in Africa, and co-infection is common. However, the effects of filarial infection on the risk of severe malaria are unknown. We used the remaining serum samples from a large cohort study in Muheza, Tanzania to describe vector-borne filarial sero-reactivity among young children and to identify associations between exposure to filarial parasites and subsequent severe malaria infections. We identified positive filarial antibody responses (as well as positive antibody responses to Strongyloides stercoralis) among infants as young as six months. In addition, we found a significant association between filarial seropositivity at six months of age and subsequent severe malaria. Specifically, infants who developed severe malaria by one year of age were 3.9 times more likely (OR = 3.9, 95% CI: 1.2, 13.0) to have been seropositive for filarial antigen at six months of age compared with infants who did not develop severe malaria.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1
Receiver operating curves for filaria (a), Strongyloides (b) using sera from US naïve donors as negative controls and from parasitologically proven infected donors as positive controls. The analysis suggested good performance characteristics for both assays, with optimal cutoff values for seropositivity of 107 for filaria and 170 for Strongyloides.
Fig 2. Flowchart of children and samples…
Fig 2. Flowchart of children and samples included in the study.
A total of 471 children were assessed for eligibility in the study. Children were excluded from the study due to HIV or sickle cell anemia, if it was a multiple birth, or if they moved from the study area. Children with blood samples at 6 months (n = 261 samples) and 1 year (n = 196 samples) were used for the risk factor analysis, of which 180 children had serum for the assays and a positive blood smear between 6 months and one year of age, and 125 children had serum and a positive blood smear between one year and 18 months of age.
Fig 3. Proportions of children seropositive for…
Fig 3. Proportions of children seropositive for filaria and for Strongyloides by age.
The proportion of children with filarial antibodies increased with age: 16.8% at 6 months, 18.9% at one year, 32.9% at 1.5 years, 39.2% at 2 years to 60.0% at 2.5 years. In contrast, the proportion of children with antibodies to Strongyloides stayed fairly constant: 8.1% at 6 months, 3.1% at 1 year, 4.5% at 1.5 years, 5.4% at 2 years and 8.0% at 2.5 years.
Fig 4. Proportions of children who subsequently…
Fig 4. Proportions of children who subsequently developed severe malaria by filaria serostatus and age.
The proportion of children with filarial antibodies who developed severe malaria over the subsequent 6 months was 12.2% at 6 months of age and 5.7% at one year. The proportions of children without filarial antibodies who developed severe malaria over the ensuing 6 months was lower: 2.83% at 6 months and 0.04% at one year. No subsequent severe malaria events were observed at time points past 18 months of age in these subjects.
Fig 5. Cytokine profiles of children in…
Fig 5. Cytokine profiles of children in the study at 6 months by filarial serostatus, stratified by whether they experienced (“Severe Malaria”) or did not experience (“No Severe Malaria”) severe malaria between 6 and 12 months of age.
No significant differences in cytokine levels were detected for children who did versus did not develop severe malaria.
Fig 6. Cytokine profiles of children in…
Fig 6. Cytokine profiles of children in the study at 12 months by filarial serostatus, stratified by whether they experienced (“Severe Malaria”) or did not experience (“No Severe Malaria”) severe malaria between 12 and 18 months of age.

References

    1. Kung'u JK, Goodman D, Haji HJ, Ramsan M, Wright VJ, Bickle QD, et al. Early helminth infections are inversely related to anemia, malnutrition, and malaria and are not associated with inflammation in 6- to 23-month-old Zanzibari children. Am J Trop Med Hyg. 2009;81(6):1062–70. Epub 2009/12/10. doi: .
    1. Crompton DW, Nesheim MC. Nutritional impact of intestinal helminthiasis during the human life cycle. Annu Rev Nutr. 2002;22:35–59. Epub 2002/06/11. doi: .
    1. World Health Organization. Key Malaria Facts, 2012. Available from: .
    1. World Health Organization. World Malaria Report 2017. Geneva, Switzerland: World Health Organization, November 29, 2017, Licence: CC BY-NC-SA 3.0 IGO.
    1. Trampuz A, Jereb M, Muzlovic I, Prabhu RM. Clinical review: Severe malaria. Crit Care. 2003;7(4):315–23. doi: ; PubMed Central PMCID: PMCPMC270697.
    1. Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends in parasitology. 2009;25(5):220–7. Epub 2009/04/08. doi: .
    1. Streit T, Lafontant JG. Eliminating lymphatic filariasis: a view from the field. Ann N Y Acad Sci. 2008;1136:53–63. doi: .
    1. Simonsen PE, Pedersen EM, Rwegoshora RT, Malecela MN, Derua YA, Magesa SM. Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission. PLoS Negl Trop Dis. 2010;4(6):e696 doi: ; PubMed Central PMCID: PMCPMC2879369.
    1. Meyrowitsch DW, Simonsen PE, Makunde WH. Bancroftian filariasis: analysis of infection and disease in five endemic communities of north-eastern Tanzania. Ann Trop Med Parasitol. 1995;89(6):653–63. .
    1. Simonsen PE, Meyrowitsch DW, Jaoko WG, Malecela MN, Mukoko D, Pedersen EM, et al. Bancroftian filariasis infection, disease, and specific antibody response patterns in a high and a low endemicity community in East Africa. Am J Trop Med Hyg. 2002;66(5):550–9. .
    1. Malecela M.N., Lazarus W, Mwingira U, Mwakitalu E, Makene C, Kabali C, et al. Eliminating LF: a progress report from Tanzania. Journal of Lymphoedema. 2009;4(1):10–2.
    1. van den Berg H, Kelly-Hope LA, Lindsay SW. Malaria and lymphatic filariasis: the case for integrated vector management. Lancet Infect Dis. 2013;13(1):89–94. doi: .
    1. World Health Organization. Geographical distribution of arthropod-borne diseases and their principal vectors World Health Organization; [Internet]. 1989.
    1. Ellman R, Maxwell C, Finch R, Shayo D. Malaria and anaemia at different altitudes in the Muheza district of Tanzania: Childhood morbidity in relation to level of exposure to infection. Annals of Tropical Medicine and Parasitology. 1998;92(7):741–53. PubMed PMID: WOS:000076972800001.
    1. Manguin S, Bangs MJ, Pothikasikorn J, Chareonviriyaphap T. Review on global co-transmission of human Plasmodium species and Wuchereria bancrofti by Anopheles mosquitoes. Infect Genet Evol. 2010;10(2):159–77. doi: .
    1. Mboera LEG, Senkoro KP, Rumisha SF, Mayala BK, Shayo EH, Mlozi MRS. Plasmodium falciparum and helminth coinfections among schoolchildren in relation to agro-ecosystems in Mvomero District, Tanzania. Acta Tropica. 2011;120(1–2):95–102. doi: PubMed PMID: WOS:000295304900013.
    1. Burkot TR, Molineaux L, Graves PM, Paru R, Battistutta D, Dagoro H, et al. The prevalence of naturally acquired multiple infections of Wuchereria bancrofti and human malarias in anophelines. Parasitology. 1990;100 Pt 3:369–75. .
    1. Simonsen PE, Derua YA, Kisinza WN, Magesa SM, Malecela MN, Pedersen EM. Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission. BMC Infectious Diseases. 2013;13(1):335 doi:
    1. Nacher M, Singhasivanon P, Yimsamran S, Manibunyong W, Thanyavanich N, Wuthisen R, et al. Intestinal helminth infections are associated with increased incidence of Plasmodium falciparum malaria in Thailand. J Parasitol. 2002;88(1):55–8. doi: .
    1. Murray J, Murray A, Murray M, Murray C. The biological suppression of malaria: an ecological and nutritional interrelationship of a host and two parasites. Am J Clin Nutr. 1978;31(8):1363–6. .
    1. Lyke KE, Dicko A, Dabo A, Sangare L, Kone A, Coulibaly D, et al. Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. Am J Trop Med Hyg. 2005;73(6):1124–30. Epub 2005/12/16. doi: 73/6/1124 [pii]. ; PubMed Central PMCID: PMCPMC2738948.
    1. Nacher M. Worms and malaria: blind men feeling the elephant? Parasitology. 2008;135(7):861–8. doi: .
    1. Spiegel A, Tall A, Raphenon G, Trape JF, Druilhe P. Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg. 2003;97(2):198–9. .
    1. Brandao E, Bonfim C, Cabral D, Lima JL, Aguiar-Santos AM, Maciel A, et al. Mapping of Wuchereria bancrofti infection in children and adolescents in an endemic area of Brazil. Acta Trop. 2011;120(1–2):151–4. doi: .
    1. Michael E, Bundy DA, Grenfell BT. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology. 1996;112 (Pt 4):409–28. .
    1. Metenou S, Dembele B, Konate S, Dolo H, Coulibaly SY, Coulibaly YI, et al. Patent Filarial Infection Modulates Malaria-Specific Type 1 Cytokine Responses in an IL-10-Dependent Manner in a Filaria/Malaria-Coinfected Population. Journal of Immunology. 2009;183(2):916–24. doi: PubMed PMID: WOS:000267812600017.
    1. Hartgers FC, Obeng BB, Kruize YC, Dijkhuis A, McCall M, Sauerwein RW, et al. Responses to malarial antigens are altered in helminth-infected children. J Infect Dis. 2009;199(10):1528–35. Epub 2009/04/28. doi: .
    1. Metenou S, Dembele B, Konate S, Dolo H, Coulibaly YI, Diallo AA, et al. Filarial infection suppresses malaria-specific multifunctional Th1 and Th17 responses in malaria and filarial coinfections. J Immunol. 2011;186(8):4725–33. doi: ; PubMed Central PMCID: PMCPMC3407819.
    1. Mutabingwa TK, Bolla MC, Li JL, Domingo GJ, Li X, Fried M, et al. Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLoS Med. 2005;2(12):e407 doi: ; PubMed Central PMCID: PMCPMC1277932.
    1. Fouda GG, Leke RFG, Long C, Druilhe P, Zhou A, Taylor DW, et al. Multiplex assay for simulataneous measurement of antibodies to multiple Plasmodium falciparum antigens. Clinical and Vaccine Immunology. 2006;13:1307–13. doi:
    1. Maizels RM, Sutanto I, Gomez-Priego A, Lillywhite J, DA D. Specificity of surface molecules of adult Brugia parasites: cross-reactivity with antibody from Wuchereria, Onchocerca and other human filarial infections. Trop Med Parasitol. 1985;36(4):233–7.
    1. Beales PF, Brabin B, Dorman E, Gilles HM, Loutain L, Marsh K, et al. Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2000;94:S1–S90. PubMed PMID: WOS:000087439300001.
    1. Mandala WL, Msefula CL, Gondwe EN, Drayson MT, Molyneux ME, MacLennan CA. Cytokine Profiles in Malawian Children Presenting with Uncomplicated Malaria, Severe Malarial Anemia, and Cerebral Malaria. Clin Vaccine Immunol. 2017;24(4). doi: ; PubMed Central PMCID: PMCPMC5382826.
    1. Kabyemela E, Goncalves BP, Prevots DR, Morrison R, Harrington W, Gwamaka M, et al. Cytokine profiles at birth predict malaria severity during infancy. PLoS One. 2013;8(10):e77214 doi: ; PubMed Central PMCID: PMCPMC3795067.
    1. Nash SD, Prevots DR, Kabyemela E, Khasa YP, Lee K-L, Fried M, et al. A Malaria-Resistant Phenotype with Immunological Correlates in a Tanzanian Birth Cohort Exposed to Intense Malaria Transmission. The American Journal of Tropical Medicine and Hygiene. 2017;96(5):1190–6. doi:
    1. Weerasooriya MV, Itoh M, Islam MZ, Aoki Y, Samarawickrema WA, Kimura E. Presence and gradual disappearance of filaria-specific urinary IgG4 in babies born to antibody-positive mothers: a 2-year follow-up study. Parasitol Int. 2008;57(3):386–9. doi: .
    1. Van de Perre P. Transfer of antibody via mother's milk. Vaccine. 2003;21(24):3374–6. .
    1. McCarthy JS, Zhong M, Gopinath R, Ottesen EA, Williams SA, Nutman TB. Evaluation of a polymerase chain reaction-based assay for diagnosis of Wuchereria bancrofti infection. J Infect Dis. 1996;173(6):1510–4. doi: .
    1. Makunde WH, Kamugisha LM, Massaga JJ, Makunde RW, Savael ZX, Akida J, et al. Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis. Filaria J. 2003;2(1):15 doi: ; PubMed Central PMCID: PMCPMC293471.
    1. Lwambo NJS, Siza JE, Brooker S, Bundy DAP, Guyatt H. Patterns of concurrent hookworm infection and schistosomiasis in schoolchildren in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1999;93(5):497–502. .
    1. Kinung'hi SM, Magnussen P, Kaatano GM, Kishamawe C, Vennervald BJ. Malaria and helminth co-infections in school and preschool children: a cross-sectional study in Magu district, north-western Tanzania. PLoS One. 2014;9(1):e86510 doi: ; PubMed Central PMCID: PMCPMC3906044.
    1. Stothard JR, Sousa-Figuereido JC, Betson M, Adriko M, Arinaitwe M, Rowell C, et al. Schistosoma mansoni Infections in Young Children: When Are Schistosome Antigens in Urine, Eggs in Stool and Antibodies to Eggs First Detectable? PLOS Neglected Tropical Diseases. 2011;5(1):e938 doi:
    1. Sokhna C, Le Hesran JY, Mbaye PA, Akiana J, Camara P, Diop M, et al. Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal. Malar J. 2004;3(1):43 doi: ; PubMed Central PMCID: PMCPMC538284.
    1. Tshikuka JG, Scott ME, Gray-Donald K, Kalumba ON. Multiple infection with Plasmodium and helminths in communities of low and relatively high socio-economic status. Ann Trop Med Parasitol. 1996;90(3):277–93. .
    1. Briand V, Watier L, JY LEH, Garcia A, Cot M. Coinfection with Plasmodium falciparum and schistosoma haematobium: protective effect of schistosomiasis on malaria in senegalese children? Am J Trop Med Hyg. 2005;72(6):702–7. .
    1. Shapiro AE, Tukahebwa EM, Kasten J, Clarke SE, Magnussen P, Olsen A, et al. Epidemiology of helminth infections and their relationship to clinical malaria in southwest Uganda. Trans R Soc Trop Med Hyg. 2005;99(1):18–24. doi: .
    1. Diallo TO, Remoue F, Schacht AM, Charrier N, Dompnier JP, Pillet S, et al. Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol. 2004;26(8–9):365–9. doi: .
    1. Jaoko WG, Michael E, Meyrowitsch DW, Estambale BB, Malecela MN, Simonsen PE. Immunoepidemiology of Wuchereria bancrofti infection: parasite transmission intensity, filaria-specific antibodies, and host immunity in two East African communities. Infect Immun. 2007;75(12):5651–62. doi: ; PubMed Central PMCID: PMCPMC2168322.
    1. Beuria MK, Bal M, Dash AP, Das MK. Age-related prevalence of antibodies to infective larvae ofWuchereria bancrofti in normal individuals from a filaria-endemic region. Journal of Biosciences. 1995;20(2):167–74. doi:
    1. Filipe JA, Boussinesq M, Renz A, Collins RC, Vivas-Martinez S, Grillet ME, et al. Human infection patterns and heterogeneous exposure in river blindness. Proc Natl Acad Sci U S A. 2005;102(42):15265–70. doi: ; PubMed Central PMCID: PMCPMC1257694.
    1. Faulkner H, Gardon J, Kamgno J, Enyong P, Boussinesq M, Bradley JE. Antibody responses in onchocerciasis as a function of age and infection intensity. Parasite Immunology. 2001;23(9):509–16. doi: PubMed PMID: WOS:000171022000006.
    1. Steel C, Golden A, Kubofcik J, LaRue N, de Los Santos T, Domingo GJ, et al. Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis. Clin Vaccine Immunol. 2013;20(8):1155–61. doi: ; PubMed Central PMCID: PMCPMC3754496.
    1. Kubofcik J, Fink DL, Nutman TB. Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection. PLoS Negl Trop Dis. 2012;6(12):e1930 doi: ; PubMed Central PMCID: PMCPMC3516582.
    1. Steel C, Kubofcik J, Ottesen EA, Nutman TB. Antibody to the filarial antigen Wb123 reflects reduced transmission and decreased exposure in children born following single mass drug administration (MDA). PLoS Negl Trop Dis. 2012;6(12):e1940 doi: ; PubMed Central PMCID: PMCPMC3516579.
    1. Lobos E, Weiss N, Karam M, Taylor HR, Ottesen EA, Nutman TB. An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science. 1991;251(5001):1603–5. doi: .

Source: PubMed

3
구독하다